By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Indian firm Ocimum Biosolutions today announced it has closed on an $8 million round, which it will use to enhance its Research as a Service platform.

The company, based in Hyderabad, said that investors came from multiple sources, including its founders and existing shareholders. It provides a wide array of services including GLP-compliant microarray services, genomic reference databases, life science laboratory management solutions, and research consumables.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.